Michael Scolaro

Michael Scolaro

Nov 19, 2017

Group 6 Copy 185
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Crowdcuring the Blues: People, Technology and Research Against Depression

    Depression is not a choice, but we can choose to do something about it. Depression is a single label used...

    Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?

    Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...

    Backer Badge Funded